Transmission of SARS-CoV-2 among children and staff in German daycare centres.

Children SARS-CoV-2 daycare centres secondary attack rate transmission

Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
08 07 2022
Historique:
entrez: 1 8 2022
pubmed: 2 8 2022
medline: 3 8 2022
Statut: epublish

Résumé

In daycare centres, the close contact of children with other children and employees favours the transmission of infections. The majority of children <6 years attend daycare programmes in Germany, but the role of daycare centres in the SARS-CoV-2 pandemic is unclear. We investigated the transmission risk in daycare centres and the spread of SARS-CoV-2 to associated households. 30 daycare groups with at least one recent laboratory-confirmed SARS-CoV-2 case were enrolled in the study (10/2020-06/2021). Close contact persons within daycare and households were examined over a 12-day period (repeated SARS-CoV-2 PCR tests, genetic sequencing of viruses, symptom diary). Households were interviewed to gain comprehensive information on each outbreak. We determined primary cases for all daycare groups. The number of secondary cases varied considerably between daycare groups. The pooled secondary attack rate (SAR) across all 30 daycare centres was 9.6%. The SAR tended to be higher when the Alpha variant was detected (15.9%

Identifiants

pubmed: 35912971
doi: 10.1017/S0950268822001194
pii: S0950268822001194
pmc: PMC9343344
doi:

Banques de données

DRKS
['DRKS00023501']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e141

Références

BMC Public Health. 2022 Jan 14;22(1):98
pubmed: 35031025
Multivariate Behav Res. 2016 Jul-Aug;51(4):495-518
pubmed: 27269278
Clin Infect Dis. 2021 Aug 2;73(3):e559-e565
pubmed: 32976596
Epidemiol Infect. 2021 Sep 22;149:e213
pubmed: 34549699
Front Pediatr. 2021 Apr 09;9:613292
pubmed: 33898355
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Pediatr Res. 2021 Mar;89(4):733-737
pubmed: 32555539
bioRxiv. 2020 Sep 04;:
pubmed: 32908977
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Clin Infect Dis. 2021 Jun 15;72(12):e1146-e1153
pubmed: 33283240
Ann Intern Med. 2021 Jan;174(1):69-79
pubmed: 32941052
Front Public Health. 2021 Dec 13;9:773850
pubmed: 34976930
Clin Infect Dis. 2021 Aug 2;73(3):e754-e764
pubmed: 33560412
MMWR Morb Mortal Wkly Rep. 2022 Mar 04;71(9):341-346
pubmed: 35238860
Front Genet. 2021 Jul 28;12:711437
pubmed: 34394197
JAMA Netw Open. 2022 Apr 1;5(4):e229317
pubmed: 35482308
Braz J Infect Dis. 2020 Sep - Oct;24(5):422-427
pubmed: 32888905
Am J Otolaryngol. 2021 Mar-Apr;42(2):102872
pubmed: 33418177
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Dec;64(12):1581-1591
pubmed: 34731294
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
Biometrics. 2001 Mar;57(1):126-34
pubmed: 11252587
Int J Epidemiol. 2021 Jul 9;50(3):743-752
pubmed: 33837417
Brief Bioinform. 2021 Mar 22;22(2):642-663
pubmed: 33147627
Am J Epidemiol. 2022 Jun 27;191(7):1224-1234
pubmed: 35238329

Auteurs

Julika Loss (J)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Juliane Wurm (J)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Gianni Varnaccia (G)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Anja Schienkiewitz (A)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Helena Iwanowski (H)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Anne-Kathrin Mareike Loer (AM)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Jennifer Allen (J)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Barbara Wess (B)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Angelika Schaffrath Rosario (A)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Stefan Damerow (S)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Tim Kuttig (T)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Hanna Perlitz (H)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Anselm Hornbacher (A)

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Bianca Finkel (B)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Carolin Krause (C)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Jan Wormsbächer (J)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Anna Sandoni (A)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Ulrike Kubisch (U)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Kiara Eggers (K)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Andreas Nitsche (A)

Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany.

Aleksandar Radonic (A)

Department of Methodology and Research Infrastructure, Robert Koch Institute, Berlin, Germany.

Kathrin Trappe (K)

Department of Methodology and Research Infrastructure, Robert Koch Institute, Berlin, Germany.

Oliver Drechsel (O)

Department of Methodology and Research Infrastructure, Robert Koch Institute, Berlin, Germany.

Kathleen Klaper (K)

Department of Methodology and Research Infrastructure, Robert Koch Institute, Berlin, Germany.

Andrea Franke (A)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Antje Hüther (A)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Udo Buchholz (U)

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Walter Haas (W)

Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Lothar H Wieler (LH)

Department of Methodology and Research Infrastructure, Robert Koch Institute, Berlin, Germany.
Leadership Robert Koch Institute, Robert Koch Institute, Berlin, Germany.

Susanne Jordan (S)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH